CMB Trainers Krishanu Saha and Melissa Skala Devise Innovative Method; Better Quality Control for Biomanufacturing Stem Cells

By reprogramming cells from a patient to yield induced pluripotent stem cells, scientists and clinicians can wield a fertile and versatile resource for personalizing patient healthcare via regenerative medicine, cell therapy or disease modeling for drug testing.

Read the full article at: